We are live on ! Find out more
NA

Neuburgh Advisers Portfolio holdings

AUM $3.22B
1-Year Est. Return 3.74%
This Fund
S&P 500
This Quarter Est. Return
+0.34%
1 Year Est. Return
+3.74%
3 Year Est. Return
+55.12%
5 Year Est. Return
10 Year Est. Return
AUM
$2.86B
AUM Growth
+$67.3M
Cap. Flow
+$76.9M
Cap. Flow %
2.69%
Top 10 Hldgs %
24.5%
Holding
920
New
30
Increased
331
Reduced
229
Closed
24

Sector Composition

Rank Sector Weight
1 Financials 17.51%
2 Healthcare 17.02%
3 Technology 15.54%
4 Consumer Discretionary 13.32%
5 Industrials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXFD
751
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$123K ﹤0.01%
9,894
-29,750
-75% -$362K
BKE icon
752
Buckle
BKE
$2.37B
$122K ﹤0.01%
5,508
REX icon
753
REX American Resources
REX
$1.42B
$121K ﹤0.01%
9,996
+2,244
+29% +$30.6K
SXC icon
754
SunCoke Energy
SXC
$714M
$121K ﹤0.01%
11,288
+204
+2% +$2.32K
ALDR
755
DELISTED
Alder Biopharmaceuticals
ALDR
$121K ﹤0.01%
+9,520
New +$138K
CALM icon
756
Cal-Maine
CALM
$4.08B
$120K ﹤0.01%
2,736
GIL icon
757
Gildan
GIL
$10.2B
$120K ﹤0.01%
4,144
SSP icon
758
E.W. Scripps
SSP
$258M
$120K ﹤0.01%
9,962
CUBI icon
759
Customers Bancorp
CUBI
$2.72B
$118K ﹤0.01%
4,048
+418
+12% +$12.6K
MATW icon
760
Matthews International
MATW
$876M
$118K ﹤0.01%
2,336
SUI icon
761
Sun Communities
SUI
$15.1B
$118K ﹤0.01%
1,292
-3,978
-75% -$351K
EBIX
762
DELISTED
Ebix Inc
EBIX
$118K ﹤0.01%
1,584
+16
+1% +$1.3K
EGRX
763
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$117K ﹤0.01%
2,210
+374
+20% +$21.7K
FRGI
764
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$116K ﹤0.01%
6,290
QGEN icon
765
Qiagen
QGEN
$8.73B
$115K ﹤0.01%
3,350
TNC icon
766
Tennant Co
TNC
$1.46B
$115K ﹤0.01%
1,694
+22
+1% +$1.5K
FN icon
767
Fabrinet
FN
$16.3B
$114K ﹤0.01%
3,630
+44
+1% +$1.3K
EFII
768
DELISTED
Electronics for Imaging
EFII
$114K ﹤0.01%
4,158
NTUS
769
DELISTED
Natus Medical Inc
NTUS
$113K ﹤0.01%
3,344
DCH
770
Dauch Corp
DCH
$1.38B
$112K ﹤0.01%
7,376
+1,216
+20% +$20K
SMCI icon
771
Super Micro Computer
SMCI
$18.5B
$112K ﹤0.01%
65,960
SYNA icon
772
Synaptics
SYNA
$4.13B
$112K ﹤0.01%
2,448
+256
+12% +$11.6K
VREX icon
773
Varex Imaging
VREX
$502M
$112K ﹤0.01%
3,120
MLI icon
774
Mueller Industries
MLI
$14.7B
$111K ﹤0.01%
16,960
XENT
775
DELISTED
Intersect ENT, Inc
XENT
$111K ﹤0.01%
2,822
-8,500
-75% -$310K

Similar funds

Neuburgh Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Neuburgh Advisers held 920 positions worth $2.86B, up 2.4% from $2.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Neuburgh Advisers's Q1 2018 filing shows 30 new, 331 increased, 229 reduced and 24 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 28,176 shares worth $3.36M. The largest sale was Hartford Financial Services, an estimated $8.82M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • Neuburgh Advisers's largest Q1 2018 buy was Alnylam Pharmaceuticals: 28,176 shares worth $3.36M.
  • Neuburgh Advisers added most to Marathon Petroleum in Q1 2018, an estimated $25.3M increase.
  • Neuburgh Advisers's biggest Q1 2018 reduction was Hartford Financial Services, cutting an estimated $8.82M.
  • Neuburgh Advisers fully exited QVC Group Inc Series A in Q1 2018, selling an estimated $2.35M.
  • Neuburgh Advisers's ten largest holdings make up 24% of its $2.86B portfolio in Q1 2018.
  • Neuburgh Advisers opened 30 new positions and closed 24 in Q1 2018.
  • Neuburgh Advisers's portfolio value rose 2.4% quarter-over-quarter to $2.86B.

Based on Neuburgh Advisers's 13F filing for Q1 2018, filed 8 May 2018.